BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20665107)

  • 1. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics.
    Kheirelseid EA; Jumustafa H; Miller N; Curran C; Sweeney K; Malone C; McLaughlin R; Newell J; Kerin MJ
    Breast Cancer Res Treat; 2011 Feb; 126(1):131-40. PubMed ID: 20665107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
    Abdalla I; Thisted RA; Heimann R
    Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after bilateral breast cancer: results from a population-based study.
    Verkooijen HM; Chatelain V; Fioretta G; Vlastos G; Rapiti E; Sappino AP; Bouchardy C; Chappuis PO
    Breast Cancer Res Treat; 2007 Nov; 105(3):347-57. PubMed ID: 17186359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral breast carcinoma: clinical characteristics and its impact on survival.
    Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL
    Breast J; 2010; 16(6):625-32. PubMed ID: 21070440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
    Hartman M; Czene K; Reilly M; Adolfsson J; Bergh J; Adami HO; Dickman PW; Hall P
    J Clin Oncol; 2007 Sep; 25(27):4210-6. PubMed ID: 17878475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
    Beinart G; Gonzalez-Angulo AM; Broglio K; Mejia J; Ruggeri A; Mininberg E; Hortobagyi GN; Valero V
    Clin Breast Cancer; 2007 Dec; 7(11):867-74. PubMed ID: 18269777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
    Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
    Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
    J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral breast carcinoma. 12 years' experience].
    Maculotti L; Gandini F; Pradella P
    Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
    Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
    Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral breast cancer.
    Gogas J; Markopoulos C; Skandalakis P; Gogas H
    Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous bilateral medullary carcinoma of breast: is it metastasis or second primary?
    ; Permi HS; Kishan Prasad HL; Mohan R; Shetty KJ; Patil C
    J Cancer Res Ther; 2012; 8(1):129-31. PubMed ID: 22531532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
    Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
    Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
    Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and outcomes of contralateral breast cancers.
    Quan G; Pommier SJ; Pommier RF
    Am J Surg; 2008 May; 195(5):645-50; discussion 650. PubMed ID: 18424281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.